Use of Ultrasound and Ki-67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy.
Sean C LiebscherLyndsey J KilgoreOnalisa WinbladNika GloyeskeKelsey E LarsonChrista BalanoffLauren E NyeAnne O'DeaPriyanka SharmaBruce F KimlerQamar KhanJamie WagnerPublished in: Healthcare (Basel, Switzerland) (2023)
Ki-67 does not predict a change in tumor size or RTBC. NET does not uniformly result in a contracted response pattern of the tumor bed. Caution should be taken when using NET for the purpose of downstaging tumor size or converting borderline mastectomy/lumpectomy patients.